A patient who has undergone a primary percutaneous coronary intervention (PCI) with a stent placement is prescribed a daily dose of 81 mg of aspirin and clopidogrel. The patient asks how long the medications must be taken. What will the prescriber tell this patient about the medication regimen?

Question

Quizplus · Accepted Answer

After a primary percutaneous coronary intervention (PCI) with stent placement, it is standard practice to prescribe dual antiplatelet therapy, typically consisting of aspirin and a P2Y12 inhibitor like clopidogrel. Aspirin is usually continued indefinitely for its antiplatelet effects to prevent clot formation, while clopidogrel is often recommended for a duration of up to 12 months post-PCI to reduce the risk of stent thrombosis and other cardiovascular events. This regimen helps balance the benefits of preventing clot-related complications with the risk of bleeding.

A Patient Who Has Undergone a Primary Percutaneous Coronary Intervention